CEMI - Chembio Diagnostics, Inc.

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
7.05
-0.25 (-3.42%)
At close: 4:00PM EST
Stock chart is not supported by your current browser
Previous Close7.30
Open7.21
Bid0.00 x 0
Ask0.00 x 0
Day's Range7.01 - 7.40
52 Week Range5.05 - 7.60
Volume19,783
Avg. Volume15,625
Market Cap86.846M
Beta1.66
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Zacks Small Cap Research8 days ago

    CEMI: Moving PT to $15.5/Share On Upward Revenue Revisions, Comp Multiple Expansion

    FIOCRUZ) to purchase $8.5M worth of DPP HIV ½ and DPP Leishmania intermediate product and test components and for the related sales to occur in 2018.  This is in addition to the May 2017 announcement that FIOCRUZ would purchase $5.8M worth DPP HIV ½ test components during 2017 ($4.2M of which was fulfilled through Q3, with the remaining $1.6M expected to be shipped by year-end).

  • Zacks Small Cap Research25 days ago

    CEMI: DPP HIV/Syph, Several DPP Fever Products to Drive 2018 Growth

    By Brian Marckx, CFA NASDAQ:CEMI Q3 2017: Upside from Lateral Flow OTC. DPP HIV/Syph, Several DPP Fever Products to Drive 2018 Growth … Chembio (NASDAQ:CEMI) reported Q3 2017 financial results and provided ...

  • Capital Cubelast month

    ETFs with exposure to Chembio Diagnostics, Inc. : November 9, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Chembio Diagnostics, Inc. Here are 5 ETFs with the largest exposure to CEMI-US. Comparing the performance and risk of Chembio Diagnostics, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Thomson Reuters StreetEventslast month

    Edited Transcript of CEMI earnings conference call or presentation 8-Nov-17 9:30pm GMT

    Q3 2017 Chembio Diagnostics Inc Earnings Call

  • Capital Cube2 months ago

    ETFs with exposure to Chembio Diagnostics, Inc. : October 30, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Chembio Diagnostics, Inc. Here are 5 ETFs with the largest exposure to CEMI-US. Comparing the performance and risk of Chembio Diagnostics, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Chembio Diagnostics, Inc. :CEMI-US: Earnings Analysis: Q2, 2017 By the Numbers : October 4, 2017
    Capital Cube2 months ago

    Chembio Diagnostics, Inc. :CEMI-US: Earnings Analysis: Q2, 2017 By the Numbers : October 4, 2017

    Categories: Yahoo FinanceGet free summary analysis Chembio Diagnostics, Inc. reports financial results for the quarter ended June 30, 2017. Highlights Summary numbers: Revenues of USD 4.11 million, Net Earnings of USD -2.17 million. Gross margins narrowed from 48.38% to 46.44% compared to the same period last year, operating (EBITDA) margins now -45.81% from -64.21%. Change in operating ... Read more (Read more...)

  • Thomson Reuters StreetEvents4 months ago

    Edited Transcript of CEMI earnings conference call or presentation 9-Aug-17 8:30pm GMT

    Q2 2017 Chembio Diagnostics Inc Earnings Call

  • Capital Cube6 months ago

    ETFs with exposure to Chembio Diagnostics, Inc. : June 16, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Chembio Diagnostics, Inc. Here are 5 ETFs with the largest exposure to CEMI-US. Comparing the performance and risk of Chembio Diagnostics, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Chembio Diagnostics, Inc. :CEMI-US: Earnings Analysis: Q1, 2017 By the Numbers : June 14, 2017
    Capital Cube6 months ago

    Chembio Diagnostics, Inc. :CEMI-US: Earnings Analysis: Q1, 2017 By the Numbers : June 14, 2017

    Categories: Yahoo FinanceGet free summary analysis Chembio Diagnostics, Inc. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of Chembio Diagnostics, Inc. – Quidel Corporation, Vermillion, Inc., Bio-Rad Laboratories, Inc. Class A, Trinity Biotech Plc Sponsored ADR Class A and OraSure Technologies, Inc. (QDEL-US, VRML-US, BIO-US, TRIB-US ... Read more (Read more...)

  • Thomson Reuters StreetEvents6 months ago

    Edited Transcript of CEMI earnings conference call or presentation 9-May-17 8:30pm GMT

    Q1 2017 Chembio Diagnostics Inc Earnings Call

  • Zacks Small Cap Research7 months ago

    CEMI New Strategy Paying Dividends As Product Sales Bounce Back

    Chembio (CEMI) reported financial results for Q1 2017.  There were several noteworthy items in both the financial results and in the operating update – almost all of which we would categorize as positive.  Relative to the financials, this includes relatively strong product sales and product margin.  Relative to the operating update, this includes a host of “wins” as it relates to the company’s recently implemented strategy to gain more control over their destiny including indications that they are off to a strong start in that regard.  Q1 is also the first period where CEMI disclosed itemized sales by region and by underlying technology (i.e.

  • Capital Cube8 months ago

    ETFs with exposure to Chembio Diagnostics, Inc. : April 5, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Chembio Diagnostics, Inc. Here are 5 ETFs with the largest exposure to CEMI-US. Comparing the performance and risk of Chembio Diagnostics, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Chembio Diagnostics, Inc. :CEMI-US: Earnings Analysis: Q4, 2016 By the Numbers : March 17, 2017
    Capital Cube9 months ago

    Chembio Diagnostics, Inc. :CEMI-US: Earnings Analysis: Q4, 2016 By the Numbers : March 17, 2017

    Categories: Yahoo Finance Get free summary analysis Chembio Diagnostics, Inc. reports financial results for the quarter ended December 31, 2016. We analyze the earnings along side the following peers of Chembio Diagnostics, Inc. – Quidel Corporation, Bio-Rad Laboratories, Inc. Class A, Trinity Biotech Plc Sponsored ADR Class A and OraSure Technologies, Inc. (QDEL-US, BIO-US, TRIB-US and OSUR-US) that ... Read more (Read more...)

  • Chembio Diagnostics, Inc. :CEMI-US: Earnings Analysis: 2016 By the Numbers : March 15, 2017
    Capital Cube9 months ago

    Chembio Diagnostics, Inc. :CEMI-US: Earnings Analysis: 2016 By the Numbers : March 15, 2017

    Categories: Yahoo Finance Get free summary analysis Chembio Diagnostics, Inc. reports financial results for the year ended December 31, 2016. We analyze the earnings along side the following peers of Chembio Diagnostics, Inc. – Quidel Corporation, Bio-Rad Laboratories, Inc. Class A and OraSure Technologies, Inc. (QDEL-US, BIO-US and OSUR-US) that have also reported for this period. Highlights Gross ... Read more (Read more...)

  • Zacks Small Cap Research9 months ago

    CEMI: Surprise Rebound In Lateral Flow, Expect DPP Strong Showing In 2017

    Chembio (CEMI) reported financial results for the fourth quarter ending December 31st.  Both revenue and EPS came in very much inline with our estimates, although within the itemized revenue there were some differences – most notably lateral flow coming in much stronger than we had anticipated but which was offset by weaker than expected DPP sales.

  • Capital Cube11 months ago

    ETFs with exposure to Chembio Diagnostics, Inc. : January 9, 2017

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETFs with exposure to Chembio Diagnostics, Inc. Here are 5 ETFs with the largest exposure to CEMI-US. Comparing the performance and risk of Chembio Diagnostics, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)